Ligand Pharmaceuticals (LGND) Insider: Stock Move Analysis
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Choose the right SP 500 fund for retirement in 2024 by evaluating fees, track record, and diversification.
24,199 articlesA Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
New data from the New York Fed show a sharp rise in household pessimism as rent and food costs rise, threatening cons...
XRP is testing a rare monthly RSI low that historians say has preceded big rallies before. Traders weigh the odds as ...
A Dow industrial stock with a durable moat is grabbing attention as markets bounce. Here’s how patient buyers see a c...
The latest weekly data shows a spike in initial claims, but the broader labor market remains resilient. Analysts warn...
After a rough stretch for tech shares, Micron stock bounced back, signaling a renewed interest in memory makers. This...
The U.S. Housing and Urban Development Department unveiled a proposed rule to expand manufactured housing by allowing...
A director sold 3,000 BlackLine shares in an open-market move. Here’s how to interpret that action, what it says abou...
Ascent Developer Solutions adds a Boston-area office to serve as a regional hub for Northeast lending, signaling a br...
Investors are watching SpaceX like a rocket on countdown. This article translates historical IPO patterns into a six-...
A quiet neighborhood was rattled when scammers posed as federal agents and urged a couple to convert savings into gol...
Sandisk stock just jumped, and investors want to know why. This article breaks down the key catalysts behind the move...